Headache News and Research

Latest Headache News and Research

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

In a recent article published in the journal Science Immunology, researchers in the United States performed a longitudinal cohort study in a golden hamster model to investigate the sensory-altering mechanisms induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared to an influenza A virus (IAV).

11 May 2023

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart's ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology.

10 May 2023

Study may provide new avenues for addressing somatosensory symptoms of long COVID

COVID-19, the disease resulting from SARS-CoV-2 infection, is associated with highly variable clinical outcomes that range from asymptomatic disease to death.

9 May 2023

High-dose drug for erectile dysfunction improves long-term blood sugar levels in diabetes patients

A small group of patients with type 2 diabetes significantly improved their long-term blood sugar levels when treated with high-dose tadalafil, a medication used to treat erectile dysfunction.

5 May 2023

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

Scientists discuss hantavirus infections, which are a type of viral hemorrhagic fever that can be transmitted to humans through exposure to infected rodents in endemic areas.

30 Apr 2023

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.

27 Apr 2023

Medical management of pituitary apoplexy yields similar results to surgery, finds study

Multicenter International Study, Led by Cedars-Sinai and Presented at American Association of Neurological Surgeons Scientific Meeting, Finds Medical Management Yields Similar Results to Surgery

26 Apr 2023

Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever

Researchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and periodic fever syndrome.

25 Apr 2023

Most kids recover from Lyme disease within six months of completing antibiotic treatment

A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new joint study from Children's National Research Institute and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, published in Pediatric Research.

21 Apr 2023

Is there an association between post COVID-19 syndrome and cognitive impairment?

Researchers examined the cognitive characteristics of patients with post-coronavirus disease 2019 syndrome.

21 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

New drug may offer relief for people with difficult-to-treat migraine

The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

20 Apr 2023

VA and NIH launch new study to better understand chronic symptoms of Gulf War Illness

The Department of Veterans Affairs (VA) and National Institutes of Health have launched a study to gain a better understanding of the chronic symptoms of Gulf War Illness.

17 Apr 2023

The prevalence and factors contributing to presenteeism with COVID-19

Researchers conducted an observational cohort study among healthcare workers.

14 Apr 2023

Genomic study reveals Babesia duncani's pathogenicity and virulence

'Tis the season for hiking now that spring has arrived and temperatures are on the upswing. But with hikes come insect bites and on the increase in North America is babesiosis, a malaria-like disease spread especially between May and October by a tick.

13 Apr 2023

Vitamin and mineral supplements may help reduce aggressive behaviors in children and youth

A systematic review published in the journal Aggression and Violent Behavior describes the effectiveness of nutritional supplements in reducing excessive aggression in children and adolescents.

11 Apr 2023

Intermittent fasting vs. calorie restriction: which diet reduces the risk of type 2 diabetes more?

Researchers performed randomized controlled trials among adults at a higher risk of developing type 2 diabetes.

10 Apr 2023

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Study examines the causal role of insomnia symptoms on 11,409 health related-symptoms

Researchers performed Mendelian randomization phenome-wide association study of insomnia symptoms using 11,409 outcome variables.

6 Apr 2023

What is the relationship between COVID-19 vaccination and the occurrence of long-COVID symptomatology?

Researchers evaluated the incidence of long coronavirus disease symptoms among COVID 2019 patients,

31 Mar 2023

Headache News and Research

Latest Headache News and Research

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

Study may provide new avenues for addressing somatosensory symptoms of long COVID

High-dose drug for erectile dysfunction improves long-term blood sugar levels in diabetes patients

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Medical management of pituitary apoplexy yields similar results to surgery, finds study

Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever

Most kids recover from Lyme disease within six months of completing antibiotic treatment

Is there an association between post COVID-19 syndrome and cognitive impairment?

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

New drug may offer relief for people with difficult-to-treat migraine

VA and NIH launch new study to better understand chronic symptoms of Gulf War Illness

The prevalence and factors contributing to presenteeism with COVID-19

Genomic study reveals Babesia duncani's pathogenicity and virulence

Vitamin and mineral supplements may help reduce aggressive behaviors in children and youth

Intermittent fasting vs. calorie restriction: which diet reduces the risk of type 2 diabetes more?

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

Study examines the causal role of insomnia symptoms on 11,409 health related-symptoms

What is the relationship between COVID-19 vaccination and the occurrence of long-COVID symptomatology?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in